中国医药导报
中国医药期刊欢迎您 今天是   2025年4月5日星期六
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  论著 本期目录 | 过刊浏览 | 高级检索 |
口腔扁平苔藓患者外周血中ASH1L及其相关调控因子表达与免疫功能相关性
王方方1      汪鹰2      蔡扬3▲
1.贵州医科大学口腔医学院,贵州贵阳   550004;
2.四川大学华西口腔医院种植修复科,四川成都   610000;
3.贵州医科大学附属口腔医院牙周黏膜科,贵州贵阳   550004
Correlation between expression of ASH1L and its related regulatory factors in peripheral blood of patients with oral lichen planus and immune function
WANG Fangfang1   WANG Ying2   CAI Yang3▲
1.School of Stomatology, Guizhou Medical University, Guizhou Province, Guiyang   550004, China; 
2.Department of Implant Prosthetics, West China Hospital of Stomatology of Sichuan University, Sichuan Province, Chengdu   610000, China; 
3.Department of Periodontics and Oral Medicine, Stomatological Hospital Affiliated to Guizhou Medical University, Guizhou Province, Guiyang   550004, China
全文: PDF (663 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析口腔扁平苔藓(OLP)患者外周血中ASH1L及其相关调控因子表达与免疫功能的相关性,探讨其在OLP发病机制中的作用及意义。 方法 收集2018年8月至2019年8月贵州医科大学附属口腔医院40例OLP患者(OLP组)和20名同期体检健康者(对照组)的外周血。采用流式细胞术及散射比浊法检测两组细胞免疫及体液免疫相关指标水平,实时荧光定量PCR检测两组外周血单个核细胞中ASH1L、泛素编辑酶A20、白细胞介素-6(IL-6)mRNA相对表达量及其与OLP免疫指标的相关性。 结果 OLP组中CD3+、CD3+CD4+、CD3+CD8+、总T+B+NK细胞、IgM水平均低于对照组,CD19+、CD4+/CD8+、补体C3及C4水平均高于对照组,差异有统计学意义(P < 0.05)。OLP组ASH1L及A20 mRNA相对表达量低于对照组,IL-6 mRNA高于对照组,差异有统计学意义(P < 0.05)。OLP组ASH1L mRNA相对表达量与IgG水平呈正相关(r > 0,P < 0.05)。A20 mRNA相对表达量与CD8+、IgA水平呈正相关(r > 0,P < 0.05),与CD4+/CD8+呈负相关(r < 0,P < 0.05)。 结论 ASH1L及其相关调控因子在OLP患者外周血中表达异常且与免疫指标水平相关,在OLP免疫相关发病机制中发挥了一定作用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王方方1 汪鹰2 蔡扬3▲
关键词 口腔扁平苔藓ASH1L泛素编辑酶A20白细胞介素-6    
Abstract:Objective To analyze the correlation between the expression of ASH1L and its related regulatory factors in the peripheral blood of patients with oral lichen planus (OLP) and the immune function, and to explore its role and significance in the pathogenesis of OLP. Methods The peripheral blood of 40 OLP patients (OLP group) and 20 healthy volunteers (control group) were collected from the Stomatological Hospital Affiliated to Guizhou Medical University from August 2018 to August 2019. Flow cytometry and scattering turbidimetry were used to detect the levels of cellular immunity and humoral immunity. The relative expression levels of ASH1L, ubiquitin editing enzyme A20, and interleukin-6 (IL-6) mRNA in peripheral blood mononuclear cells of the two groups and their correlation with OLP immune indexes were detected by quantitative real-time PCR. Results The levels of CD3+, CD3+CD4+, CD3+CD8+, total T+B+NK cells, and IgM in OLP group were lower than those in control group, and CD19+, CD4+/CD8+, complement C3, and C4 levels were lower than those in control group, with statistical significance (P < 0.05). The relative expression levels of ASH1L and A20 mRNA in OLP group were lower than those in control group, and IL-6 mRNA in OLP group was higher than that in control group, with statistical significance (P < 0.05). The relative expression of ASH1L mRNA in OLP group was positively correlated with the level of IgG (r > 0, P < 0.05). The relative expression of A20 mRNA was positively correlated with the levels of CD8+ and IgA (r > 0, P < 0.05), and negatively correlated with the CD4+/CD8+ (r < 0, P < 0.05). Conclusion The abnormal expression of ASH1L and its related regulatory factors in the peripheral blood of OLP patients is correlated with the level of immune indicators, and plays a certain role in the immune-related pathogenesis of OLP.
Key wordsOral lichen planus    ASH1L    Ubiquitin editing enzyme A20    Interleukin-6
    
基金资助:国家自然科学基金资助项目(81460104)。
通讯作者: ▲通讯作者   
作者简介: 王方方(1993.4-),女,贵州医科大学口腔医院2018级口腔临床医学专业在读硕士研究生;研究方向:牙周黏膜。
引用本文:   
王方方1 汪鹰2 蔡扬3▲. 口腔扁平苔藓患者外周血中ASH1L及其相关调控因子表达与免疫功能相关性[J]. 中国医药导报, 2021, 18(24): 8-10,16.
WANG Fangfang1 WANG Ying2 CAI Yang3▲. Correlation between expression of ASH1L and its related regulatory factors in peripheral blood of patients with oral lichen planus and immune function. 中国医药导报, 2021, 18(24): 8-10,16.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2021/V18/I24/8

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司